A study published in JCO Clinical Cancer Informatics demonstrates that machine learning models incorporating patient-reported outcomes and wearable sensor data can predict which patients with ...

Imagine you are developing antibodies—drugs precisely aimed at a target, for example a viral protein or onco-marker. You test a series of antibodies and find that some work, while others do not.

Lendbuzz is targeting a valuation of about $1.5 billion via IPO. Here are top reasons why Lendbuzz IPO isn't attractive to ...